Sangamo Therapeutics Inc Stock Ownership - Who owns Sangamo Therapeutics?

Insider buying vs selling

Have Sangamo Therapeutics Inc insiders been buying or selling?
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2024-06-11892$0.61
Sandy MacRaePRESIDENT CEO AND DIRECTOR2024-05-257,492$0.60
Scott B. WilloughbySVP GEN. COUNSEL SECRETARY2024-05-251,336$0.60
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2024-05-251,508$0.60
Amy PoolerVP HEAD OF RESEARCH2024-05-25493$0.60
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2024-05-251,371$0.60
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2024-05-241,787$0.60
Amy PoolerVP HEAD OF RESEARCH2024-05-24702$0.60
Scott B. WilloughbySVP GEN. COUNSEL SECRETARY2024-05-241,400$0.60
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2024-05-241,787$0.60

1 of 4

SGMO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMO insiders and whales buy or sell their stock.

SGMO Shareholders

What type of owners hold Sangamo Therapeutics Inc stock?
Wasatch Advisors LP9.70%20,132,324$7.99MInstitution
Biogen Inc8.51%17,652,466$7.01MInsider
Armistice Capital LLC8.17%16,958,477$6.73MInstitution
Blackrock Inc6.40%13,277,637$5.27MInstitution
Vanguard Group Inc5.88%12,200,368$4.84MInstitution
Acadian Asset Management LLC2.38%4,943,260$1.96MInstitution
Ra Capital Management LP1.77%3,683,002$1.46MInsider
Geode Capital Management LLC1.62%3,363,791$1.34MInstitution
D E Shaw Co Inc1.48%3,067,435$1.22MInstitution
State Street Corp1.33%2,751,804$1.09MInstitution

1 of 3

SGMO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMO48.65%15.59%Net SellingNet Selling
MAIA3.03%20.26%Net BuyingNet Buying
MRNS81.79%18.21%Net Buying
CMRX43.23%31.76%Net Buying

Sangamo Therapeutics Stock Ownership FAQ

Who owns Sangamo Therapeutics?

Sangamo Therapeutics (NASDAQ: SGMO) is owned by 48.65% institutional shareholders, 15.59% Sangamo Therapeutics insiders, and 35.76% retail investors. Biogen Inc is the largest individual Sangamo Therapeutics shareholder, owning 17.65M shares representing 8.51% of the company. Biogen Inc's Sangamo Therapeutics shares are currently valued at $6.97M.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.